“…For example, stroke is a sexually dimorphic disease, starting from male and female differences in stroke incidence and outcome in humans, to experimental studies that clearly show differences in ischemic sensitivity between male and female animals. This sex difference in ischemic brain injury persisted in genetic in vivo models of hypertension (Alkayed, et al, 1998) and diabetes (Hurn and Macrae, 2000;Toung, et al, 2000;Vannucci, et al, 2001;Sieber, et al, 2001), suggesting that fundamental molecular mechanisms of ischemic cell death may be gender dependent. These differences are in part due to the protective effect of the female sex hormone estrogen (Hurn and Macrae, 2000;McCullough, et al, 2003;Liu, et al, 2004), since ovariectomy increases ischemic brain damage in female rats (Alkayed, et al, 1998) and mice (McCullough, et al, 2005), and estrogen replacement is protective against cerebral ischemia in ovariectomized rats (Rusa, et al, 1999) and mice (McCullough, et al, 2005) and in reproductively senescent male and female rats (Alkayed, et al, 2000).…”